-

DeciBio Consulting Advances in the Vault Consulting 50

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting, a strategy consulting firm focused on precision medicine, was again named a top consulting firm to work for in North America. Vault.com awarded DeciBio the #30 ranking on its 2022 edition of its signature list, the Vault Consulting 50. DeciBio also advanced to #4 on Vault’s 2022 Best Boutique Consulting Firms list. DeciBio is one of the youngest firms on either list.

In awarding these rankings, Vault cited superlatives such as DeciBio’s career development opportunities and “chart your own path” philosophy, DeciBio’s unique character and culture, and the fact that employees have “nothing but praise to heap on top of more praise about life at their firm.”

DeciBio also received top-10 rankings overall in various categories, including Firm Culture (#3), Innovation (#3), Relationships with Supervisors (#3), Interaction with Clients (#9), Firm Leadership (#3), Work/Life Balance (#6), Selectivity (#6), Informal Training (#7), Diversity (#8), Satisfaction (#8), and Interaction with Clients (#9).

“This feedback mirrors our founding resolution to empower our team members to write their own fulfilling stories, while supporting them with a harmonious and fun culture. Our success depends on our management team’s ability to let our employees’ passions fuel our firm’s growth. Due to that spirit, our managers now lead a venture capital firm, we have revenue-generating software products, and our content expertise continuously expands in step with the fringe of technological developments in many disruptive spaces within precision medicine,” said Stephane Budel, DeciBio’s Co-Founder.

In turn, this culture led to DeciBio’s top differentiator: thought leadership and content expertise. Senior Project Leader, Colin Enderlein, emphasized, “We have built a reputation as trusted precision medicine advisors that does not just exist behind closed doors but extends into SEC filings, global conferences, and industry reports as well. Since the earliest years at DeciBio, we have encouraged and nurtured thought leadership, which fuels the growing impact our team has in our industry.”

“Our firm has always been obsessed with the idea of creating a uniquely different consulting firm supported by a harmonious and bounding culture. External affirmations such as Vault help bolster our faith in our firm’s founding principles but also push us to work twice as hard to perpetuate and further enrich this culture as we continue to scale,” said Elle Roberts, Head of Operations & People.

After surveying verified consulting employees and interns in North America, Vault calculated the 2022 Vault Consulting 50 rankings based on the following factors: Prestige, Firm Culture, Satisfaction, Compensation, Work/Life Balance, Level of Challenge, Business Outlook, and Promotion Policies. See FirstHand’s website for results and methodology.

About DeciBio

DeciBio Consulting (www.decibio.com) is the leading strategy consulting, market intelligence, and SaaS firm dedicated to accelerating the adoption and impact of technologies enabling precision medicine.

Headquartered in Los Angeles, California, DeciBio serves a global base of clients and customers, ranging from startups to Fortune 500 healthcare corporations. DeciBio offers advisory services for growth planning, market and opportunity assessment, product and portfolio strategy, voice-of-customer feedback, technology assessment, and commercial due diligence.

Contacts

DeciBio Consulting
Elle Roberts
careers@decibio.com
310.451.4510

More News From DeciBio Consulting

Worldwide In Vitro Diagnostics (IVD) Market Forecasted to Grow at 4% p.a., Reaching $109B by 2030 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--According to a comprehensive market report authored by DeciBio Consulting LLC, “In Vitro Diagnostic (IVD) Market Report 2025-2030”, the global in vitro diagnostics market is predicted to reach $109B by 2030. This growth will be driven by increasing access to and adoption of diagnostics, the development of new therapies requiring ongoing testing, and the rise of emerging technologies (e.g., computational pathology, liquid biopsy) poised to gain clinical traction and...

Proteomics Tools Market Forecast to Grow at ~4% p.a., Reaching ~$39B by 2030 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Proteomics Tools Report: Research and Clinical markets (2025-2030).” This comprehensive report forecasts the global proteomics tools market to reach approximately $39 billion by 2030, growing at a compound annual growth rate (CAGR) of ~4% from an estimated $32 billion in 2025. DeciBio’s Proteomics Tools Market Report offers an in-dept...

Pharma R&D Services Market Forecast to Grow at 5% p.a., Reaching ~$129B by 2029 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Pharma R&D Services Market Report (2024-2029).” This comprehensive report forecasts the global pharma R&D services market to reach approximately $129 billion by 2029, growing at a compound annual growth rate (CAGR) of 5% from an estimated $101 billion in 2024. DeciBio’s Pharma R&D Services Market Report offers an in-depth...
Back to Newsroom